Equifax Inc. (NYSE:EFX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 6, 2025 Equifax Inc. reports earnings inline with expectations. Reported EPS is $2.12 EPS, expectations were $2.12. Operator: Greetings and welcome to the Equifax Corporate’s Fourth Quarter 2024 Earning Conference Call.
Equifax (EFX) Surpasses Q4 Earnings Estimates
Equifax (EFX) came out with quarterly earnings of $2.12 per share, beating the Zacks Consensus Estimate of $2.10 per share. This compares to earnings of $1.81 per share a year ago. These figures are adjusted for non-recurring items.
Equifax Inc (EFX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
Equifax Inc (EFX) reports robust financial performance with significant revenue and EPS growth, despite facing headwinds in the mortgage and hiring markets.
Equifax Inc. (EFX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsTrevor Burns - Senior Vice President, Head
Equifax Inc Q4 Profit Increases, Beats Estimates
Equifax Inc (EFX) released a profit for its fourth quarter that increased from the same period last year and beat the Street
Equifax Q4 Earnings Beat, Revenues Miss Despite Strong Segments
Equifax Inc. EFX has reported mixed fourth-quarter 2024 results, wherein earnings surpassed the Zacks Consensus Estimate, while revenues missed the same. See Zacks Earnings Calendar to stay ahead of market-making news.
abrdn plc Lowers Holdings in Equifax Inc. (NYSE:EFX)
Equifax Inc. (NYSE:EFX – Free Report) by 14.6% during the 4th quarter, Holdings Channel.com reports. The fund owned 41,969 ...
Oppenheimer Keeps Their Buy Rating on Equifax (EFX)
In a report released yesterday, Owen Lau from Oppenheimer maintained a Buy rating on Equifax (EFX – Research Report), with a price target of ...
news.stocktradersdaily5d
(EFX) Investment Report
Check the time stamp on this data. Updated AI-Generated Signals for Equifax Inc. (EFX) available here: EFX. Type a few ...
Liver Disease-Focused Akero Therapeutics Stock Soars Over 100% On Monday - Here's Why
Akero's SYMMETRY Phase 2b study showed 50mg EFX achieved 24% cirrhosis reversal in MASH patients, with improvements in liver ...
Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Equifax (EFX) and Werner Enterprises (WERN)
Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Equifax (EFX – Research Report) and Werner Enterprises ...
Akero: Reversal Of Cirrhosis With EFX Is A 'First' In F4 MASH Patients
Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...
Chicago Partners Investment Group LLC Reduces Stock Position in Equifax Inc. (NYSE:EFX)
Chicago Partners Investment Group LLC decreased its position in shares of Equifax Inc. (NYSE:EFX – Free Report) by 35.8% ...
Stocktwits on MSN2d
Equifax Stock Dives After Q4 Earnings, 2025 Guidance Miss Estimates: Retail Cheers Dividend Payment For 100-Plus Consecutive Years
Shares of data analytics firm Equifax Inc (EFX) fell nearly 7% on Thursday, heading toward their worst single-day session ...